StockTipsArenaBeta

BUY Ajanta Pharma Limited — Systematix Shares & Stock

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

bySystematix Shares & StockHorizon: NA (inferred 1 year)7 Jul 2026via Economic Times New Stock Recos

Entry₹3,374Inferred
Target₹3,829
Total upside +13.49%
Stop lossNot given
CMP₹3,283.92d ago
Active-2.67%+16.60%upside left 9 mo left
Follow Systematix Shares & Stock for new callsGet alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 2 other Long-term calls on AJANTPHARM

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:03 am IST
15 supporting3 neutral4 opposing
Supports the BUY call (15)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·23 Oct · 2d ago

Ajanta Pharma promoter releases pledge on 98,185 shares for loan repayment

NewsGoogle News·28 Sept · 4w ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·10 Aug · 3mo ago

Neutral / worth noting (3)

Q2 FY27 results scheduled — board meets 30 Oct 2026

BSE · Board Meeting·In 4 days

(opens in new tab)
Weighs against the BUY call (4)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Systematix Shares & Stock

Every call and its outcome